1. A Problematic Biomarker Trial Design. (21st July 2021) Authors: Freidlin, Boris; Korn, Edward L Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 2(2022) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An audit strategy for time-to-event outcomes measured with error: Application to five randomized controlled trials in oncology. (October 2013) Authors: Dodd, Lori E; Korn, Edward L; Freidlin, Boris; Gu, Wenjuan; Abrams, Jeffrey S; Bushnell, William D; Canetta, Renzo; Doroshow, James H; Gray, Robert J; Sridhara, Rajeshwari Journal: Clinical trials Issue: Volume 10:Number 5(2013) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Are restricted mean survival time methods especially useful for noninferiority trials?. (April 2021) Authors: Freidlin, Boris; Hu, Chen; Korn, Edward L Journal: Clinical trials Issue: Volume 18:Number 2(2021) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Augmenting randomized clinical trial data with historical control data: Precision medicine applications. (26th September 2022) Authors: Freidlin, Boris; Korn, Edward L Journal: Journal of the National Cancer Institute Issue: Volume 115:Number 1(2023) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biomarker-adaptive clinical trial designs. (December 2010) Authors: Freidlin, Boris; Korn, Edward L Journal: Pharmacogenomics Issue: Volume 11:Number 12(2010) Page Start: 1679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Biomarker-adaptive clinical trial designs. (December 2010) Authors: Freidlin, Boris; Korn, Edward L Journal: Pharmacogenomics Issue: Volume 11:Number 12(2010) Page Start: 1679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical Benefit Scales and Trial Design: Some Statistical Issues. (18th May 2022) Authors: Korn, Edward L; Allegra, Carmen J; Freidlin, Boris Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 9(2022) Page Start: 1222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Commentary on Hey and Kimmelman. (April 2015) Authors: Korn, Edward L; Freidlin, Boris Journal: Clinical trials Issue: Volume 12:Number 2(2015) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of futility monitoring guidelines using completed phase III oncology trials. (February 2017) Authors: Zhang, Qiang; Freidlin, Boris; Korn, Edward L; Halabi, Susan; Mandrekar, Sumithra; Dignam, James J. Journal: Clinical trials Issue: Volume 14:Number 1(2017) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Information time scales for interim analyses of randomized clinical trials. (August 2016) Authors: Freidlin, Boris; Othus, Megan; Korn, Edward L Journal: Clinical trials Issue: Volume 13:Number 4(2016) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗